Nicotine / THR - Guides for Policymakers & Advocates

From Safer nicotine wiki
Jump to navigation Jump to search
This page contains changes which are not marked for translation.






More Information

Nicotine / THR - Guides for Healthcare and Social Services Professionals

  • This related page will provide helpful information for anyone interested in the use of reduced risk nicotine products.

Advocates

Saving Lives - An Advocates Guide To Tobacco Harm Reduction

  • Written by AHRA - Africa Harm Reduction Alliance - 2020

Educational Materials

Nicotine science and policy Q & A

E-CIGARETTE POLICY BRIEF: Seven Things Policy Makers Need to Know

  • Quick 1 page guide
  • All references are hyperlinked to official WHO and government reports, and peer-reviewed studies

A Blueprint for Better Regulation

TPA Series: THR 101

Tobacco & Vaping 101: 50 State Analysis

TOBACCO HARM REDUCTION 101: A GUIDEBOOK FOR POLICYMAKERS

Vaping & Tobacco Harm Reduction: The Path to Saving Millions of Lives

Why

10 reasons why blanket bans of e-cigarettes and HTPs in low- and middle-income countries (LMICs) are not fit for purpose

Fear Profiteers: How E-cigarette Panic Benefits Health Activists

  • Written by Michelle Minton - Competitive Enterprises Institute - 2018

Promoting Harm Reduction Policies

2021: Reducing the smoking-related health burden in the USA through diversion to electronic cigarettes: a system dynamics simulation study

  • The simulation suggests that the promotion of e-cigarettes as a harm-reduction policy is a viable strategy, given current evidence that e-cigarettes offset or divert from smoking. Given the strong effects of implementation challenges on policy effectiveness in the short term, accurately modeling such obstacles can usefully inform policy design.
  • PDF Version
  • Citation: Selya AS. Reducing the smoking-related health burden in the USA through diversion to electronic cigarettes: a system dynamics simulation study. Harm Reduct J. 2021;18(1):36. Published 2021 Mar 20. doi:10.1186/s12954-021-00484-6
  • Acknowledgement: This work was supported by the National Institute for General Medical Sciences (NIGMS) within the National Institutes of Health (NIH), grant number P20GM121341; by the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU), grant number NNA-2016/10023. After the initial submission of this manuscript, AS became employed by Pinney Associates, Inc. which provides consulting services on tobacco harm minimization to JUUL Labs, Inc. The content presented here precedes this competing interest, and JUUL Labs, Inc. and PinneyAssociates, Inc. had any role in the conceptualization, design, analysis, interpretation, or presentation of data, nor in the decision to publish.